High expression of TARS is associated with poor prognosis of endometrial cancer.

Si, Lihui; Liu, Lianchang; Yang, Ruiqi; Li, Wenxin; Xu, Xiaohong

Si, Lihui; Liu, Lianchang; Yang, Ruiqi; Li, Wenxin; Xu, Xiaohong.

Afiliación

Si L; Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130021, China.
Liu L; Department of Intervention, The Second Hospital of Jilin University, Changchun 130021, China.
Yang R; Physical Examination Center, The Second Hospital of Jilin University, Changchun 130021, China.
Li W; Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130021, China.
Xu X; Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130021, China.

Aging (Albany NY) ; 15(5): 1524-1542, 2023 03 06.

Article en En | MEDLINE | ID: mdl-36881401

Asunto(s)

Neoplasias Endometriales; Femenino; Humanos; Neoplasias Endometriales/genética; Proliferación Celular; Bases de Datos Factuales; Nomogramas; Curva ROC; Pronóstico; Biomarcadores de Tumor

Palabras clave

TARS; biomarker; disease specific survival; endometrial cancer; overall survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google